Recent News

By Category: Public Health

J&J Announce Start of Phase 1 Clinical Trial of Ebola Vaccine

Johnson & Johnson this week announced the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies. The trial is being led by the Oxford Vaccine Group, part of the University of Oxford Department of Paediatrics. Recruitment in the trial is underway, and the first  Read More »

UC Davis Working to Help Speed Ebola Drug Production

Researchers at the University of California, Davis will explore ways to speed production of the Ebola drug with a $200,000 rapid-response grant from the National Science Foundation. Developed by Mapp Biopharmaceutical Inc. of San Diego, in collaboration with the U.S. government and partners in Canada, Zmapp is a cocktail of antibodies produced in and extracted  Read More »

‘Superbugs’ Kill India’s Babies and Pose an Overseas Threat

Tens of thousands of newborns in India are dying after being infected by antibiotic resistant bacteria.

HIV’s ability to cause AIDS is weakening over time

Rapid evolution of HIV is slowing its ability to cause AIDS, according to a study of more than 2,000 women in Africa

New 15-Minute Ebola Diagnostic to be Trialed in Guinea

A rapid, point-of-care diagnostic test for the Ebola virus will be trialed in the coming weeks at the Ebola treatment center in Conakry, Guinea